Prognosis of patients with BRCA1 -associated ovarian carcinomas depends on TP53 accumulation status in tumor cells-Reference-Cited by-同舟云学术

Prognosis of patients with BRCA1 -associated ovarian carcinomas depends on TP53 accumulation status in tumor cells

Published:2017-02 Issue:2 Volume:144 Page:369-376
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Rzepecka Iwona K.,Szafron Lukasz M.,Stys Agnieszka,Felisiak-Golabek Anna,Podgorska Agnieszka,Timorek Agnieszka,Sobiczewski Piotr,Pienkowska-Grela Barbara,El-Bahrawy Mona,Kupryjanczyk Jolanta

Funder

Polish Ministry of Science and Higher Education

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. BRCA1 and implications for response to chemotherapy in ovarian cancer;Quinn;Gynecol. Oncol.,2009

2. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer;Boyd;JAMA,2000

3. Improved survival in women with BRCA-associated ovarian carcinoma;Cass;Cancer,2003

4. Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer;Chetrit;J. Clin. Oncol.,2008

5. “BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations;Tan;J. Clin. Oncol.,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of BRCA1 /2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta‐analysis;Journal of Obstetrics and Gynaecology Research;2022-06-13

2. Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer;Journal of Cancer;2021

3. The emerging role of precision medicine in the treatment of ovarian cancer;Expert Review of Precision Medicine and Drug Development;2020-06-16

4. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies;DNA Repair;2019-08

5. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas;Cancer Biology & Therapy;2019-03-01